Arbutus Biopharma Corp: Form 8-K, filed May 31, 2022
Filed with the SEC on May 31, 2022 and accepted by EDGAR at May 31, 2022, 16:05 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001447028-22-000041. Last ingested by Listed: Nov 10, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.